US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immune Pharmaceuticals

0.0032

0.0000

Volume:- -

Turnover:- -

Market Cap:114.93K

PE:0.00

High:0.0032

Open:0.0032

Low:0.0032

Close:0.0032

52wk High:0.0032

52wk Low:0.0032

Shares:35.92M

Float Shares:8.70M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8252

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Immune Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.immunepharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Immune Pharmaceuticals Inc. is focused on developing the next generation of monoclonal antibodies to address significant unmet medical needs in the treatment of cancer and inflammatory diseases. Our goal is to improve patients' lives through targeted medicine.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IMNP/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMNP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMNP\",,,,,undefined,":{"symbol":"IMNP","market":"US","secType":"STK","nameCN":"Immune Pharmaceuticals","latestPrice":0.0032,"timestamp":1550869200000,"preClose":0.0032,"halted":0,"volume":0,"delay":0,"floatShares":8700000,"shares":35915267,"eps":-1.82523,"marketStatus":"Trading","change":0,"latestTime":"12-22 14:13:08 EST","open":0.0032,"high":0.0032,"low":0.0032,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.82523,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.0032,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMNP\",,,,,undefined,":{"symbol":"IMNP","floatShares":8700000,"roa":"--","roe":"--","lyrEps":0,"shares":35915267,"dividePrice":0,"high":0.0032,"amplitude":0,"preClose":0.0032,"low":0.0032,"week52Low":0.0032,"pbRate":"--","week52High":0.0032,"institutionHeld":0,"latestPrice":0.0032,"eps":-1.82523,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.82523,"open":0.0032},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMNP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-09-03","symbol":"IMNP","name":"Immune Pharmaceuticals Inc.","time":"","type":"earning","dateTimestamp":1535947200000,"reportTimeType":""},{"market":"US","date":"2018-05-15","symbol":"IMNP","name":"Immune Pharmaceuticals Inc","time":"","type":"earning","dateTimestamp":1526356800000,"reportTimeType":"","actualEps":-0.15},{"market":"US","date":"2018-04-02","symbol":"IMNP","name":"Immune Pharmaceuticals Inc","time":"","type":"earning","dateTimestamp":1522641600000,"reportTimeType":"","actualEps":-0.7},{"market":"US","date":"2017-11-15","symbol":"IMNP","name":"Immune Pharmaceuticals Inc","time":"","type":"earning","dateTimestamp":1510722000000,"reportTimeType":"","actualEps":-0.34},{"market":"US","date":"2017-08-21","symbol":"IMNP","name":"Immune Pharmaceuticals Inc","time":"","type":"earning","dateTimestamp":1503288000000,"reportTimeType":"","actualEps":-0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMNP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMNP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.immunepharma.com","stockEarnings":[{"period":"1week","weight":-0.9749},{"period":"1month","weight":-0.9749},{"period":"3month","weight":-0.9749},{"period":"6month","weight":-0.9749},{"period":"1year","weight":-0.9749},{"period":"ytd","weight":-0.9749}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Immune Pharmaceuticals Inc. is focused on developing the next generation of monoclonal antibodies to address significant unmet medical needs in the treatment of cancer and inflammatory diseases. Our goal is to improve patients' lives through targeted medicine.","exchange":"NASDAQ","name":"Immune Pharmaceuticals","nameEN":"Immune Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMNP\",market:\"US\",,,undefined,":null}}